PF-ILD is a suspect disease in the area of infectious respiratory digestive and endocrine disorders, clinical performance is complex and often involves multi-systematic strain. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many infectious respiratory digestive endocrine disorders that were previously difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes based on disease changes.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PF-ILD. The platform serves China's international medical service system, a team of domestic and foreign experts in the field of infectious respiratory digestive and endocrine disorders, to provide the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.